SPN and infection: While we confirmed JAK-dependency of NAMPT upregulation in response to Spn D39 infection using the JAK inhibitor Ruxolitinib (Supplementary Fig. 5A), repression of NMNAT1 was not JAK-dependent (Supplementary Fig. 5B).